Analysis of factors influencing the readiness for coronavirus vaccination: results of a survey of HIV-infected patients


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Objective. To investigate the factors influencing the readiness of HIV-infected patients to be vaccinated against coronavirus infection in order to clarify measures aimed at preventing COVID-19 infection. Subjects and methods. The investigation conducted in the period February 9 to March 26, 2021, which involved 113 HlV-infected patients registered in the Specialized Research Department of AIDS Epidemiology and Prevention, Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being. The questionnaire method was used. Results. 32.7% of the respondents expressed more likely a positive attitude to vaccination. A total of 23.9% of the respondents rated their coronavirus vaccination awareness as high as possible. Their readiness for vaccination was higher than that in respondents with low awareness (40.7 and 12.5%, respectively; p = 0.017). The information obtained from the attending physician (63.7%) was the most trusted when making a decision on vaccination in the surveyed group. 24.3% of the survey participants showed the maximum interest in obtaining information. 47.1% of them displayed their readiness for vaccination; 23.5% were unready for the latter. Conclusion. The results of the study could identify the factors influencing the patient’s decision to be vaccinated against COVID-19, which should be taken into account when advising on vaccination issues.

Full Text

Restricted Access

About the authors

Ulyana A. Kuimova

Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being

Email: ulyanakuimova@gmail.com
Cand. Med. Sci., Researcher

Valentina V. Belyaeva

Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being

Email: labora-et-ora@yandex.ru
МБ, Leading Researcher

Nadezhda V. Kozyrina

Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being

Email: nad-kozyrina@yandex.ru
Cand. Med. Sci., Researcher

Ekaterina I. Kulabukhova

Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being; Peoples' Friendship University of Russia

Email: ekulabukhova@mail.ru
Infectiologist

Marina D. Goliusova

Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being

Email: mad2501@yandex.ru
Infectiologist

Artem N. Narkevich

Prof. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University, Ministry of Health of Russia

Email: narkevichart@gmail.com
МD, Associate Professor, Head, Department of Medical Cybernetics and Informatics, Head, Laboratory of Medical Cybernetics and Management in Healthcare

References

  1. Актуальная эпидемическая ситуация в России и мире 2021 год. Федеральная служба по надзору в сфере защиты прав потребителей и благополучия человека. https://www.rospotrebnadzor.ru/region/korono_virus/epid.php
  2. Ладная Н.Н., Козырина Н.В., Бабихина К.А., Михайлов А.В., Годлевская М.В., Егорова Н.В. и др. Результаты исследования «Изучение распространенности коронавирусной инфекции COVID-19 среди инфицированных ВИЧ пациентов в России и влияния эпидемии коронавирусной инфекции COVID-19 на оказание медицинской помощи при ВИЧ-инфекции». dannye-issledovaniya-vich-i-sovid-19.pdf
  3. Кравченко А.В., Куимова У.А., Голиусова М.Д., Козырина Н.В., Кулабухова Е.И. Особенности течения коронавирусной инфекции у больных ВИЧ-инфекцией. Материалы Российской научно-практической конференции «Управляемые и другие социально-значимые инфекции: диагностика, лечение и профилактика». Спб., 3-4 февраля 2021 г. Журнал Инфектологии 2021; 13(1, приложение 1): 70-71.
  4. Hoffmann C., Casado J.L., Harter G., Vizcarra P., Moreno A., Cattaneo D. et al. Immune deficiency is a risk factor for severe COVID-19 in people living with HIV. HIV Med. 2021; 22(5): 372-78. doi: 10.1111/hiv.13037.
  5. Del Amo J., Polo R., Moreno S., Diaz A., Martinez E., Arribas J.R. et al.; The Spanish HIV/COVID-19 Collaboration. Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy: A Cohort Study. Ann. Intern. Med. 2020; 173: 536-41.
  6. Правила профилактики новой коронавирусной инфекции. Федеральная служба по надзору в сфере защиты прав потребителей и благополучия человека. https: //www. rospotrebnadzor.ru/about/info/news_time/news_details.php
  7. Вакцина для профилактики COVID-19. Федеральная служба по надзору в сфере защиты прав потребителей и благополучия человека. https://www.rospotrebnadzor.ru/region/korono_virus/versuscovid.php
  8. People with Certain Medical Conditions. Centers for desease control and prevention. https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-with-medical-conditions.html
  9. Guidance for COVID-19 and People with HIV. https://clinicalinfo.hiv.gov/en/guidelines/covid-19-and-persons-hiv-interim-guidance/interim-guidance-covid-19-and-persons-hiv
  10. Вакцины от COVID-19 при ВИЧ. https://www.unaids.org/ru/resources/documents/2021/covid19-vaccines-and-hiv
  11. Вакцинация: ключ на старт! Аналитический обзор. M.: ВЦИОМ, 2020. https://wciom.ru/analytical-reviews/analiticheskii-obzor/vakcinacija-kljuch-na-start

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2021 Bionika Media